Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-8.10M
↑ 25% above average
Average (5y)
$-10.81M
Historical baseline
Range
High:$-173351.00
Low:$-30.24M
CAGR
+115.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-8.10M | -4.0% |
| 2024 | $-7.79M | +33.6% |
| 2023 | $-11.73M | -71.9% |
| 2022 | $-6.83M | +77.4% |
| 2021 | $-30.24M | -17345.0% |
| 2020 | $-173351.00 | - |